A study has discovered that using a proton pump inhibitor (PPI) raises mortality risk
Bariatric surgery patients who has suffered from gastroesophageal reflux disease (GERD) or heartburn will probably confess that the experience can be extremely painful. They will also tell you that finding relief is important but very difficult. Most of Bariatric surgery patients use medication to find this relief. But a study conducted in 2018 by scientists from Washington University of Medicine discovered that using a PPI, particularly the PPI known as omeprazole or Prilosec, increases the risk of dying.
The lead researcher of the study, Dr. Amantha , said the following disturbing statement:“If 500 Bariatric surgery patients took the medication for about a year, then there would be one excess death that could be attributed to using this class of medication called PPI.”